Article info
Original Articles
Efficacy and tolerability of the ifosfamide–epirubicin combination in relapsed ovarian cancer
- Address correspondence and reprint requests to: Florence Joly, MD, PhD, Service d'oncologie médicale, Centre Francois Baclesse, Route de Lion sur Mer, BP 5026, 14076 Caen, Cedex 05, France. Email: f.joly{at}baclesse.fr
Citation
Efficacy and tolerability of the ifosfamide–epirubicin combination in relapsed ovarian cancer
Publication history
- First published January 1, 2006.
Online issue publication
December 03, 2018
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2006, IGCS